(Q48720971)

14 February 2018

title

Interaction of flunarizine with dopamine D2 and D1 receptors (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

5 December 2022

1

C. Ambrosio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833208

5 December 2022

author name string

E. Stefanini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833208

5 December 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

14 February 2018

17 May 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1833208

full work available at URL

5 December 2022

number of pages

3

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:001429999190526V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

https://api.elsevier.com/content/article/PII:001429999190526V?httpAccept=text/plain

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

European Journal of Pharmacology

5 December 2022

published in

1 reference

14 February 2018

volume

197

1 reference

14 February 2018

issue

2-3

1 reference

14 February 2018

page(s)

221-223

1 reference

14 February 2018

Flunarizine increases PRL secretion in normal and in migraineous women

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine

5 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: role of disulfide and sulfhydryl groups

5 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain

5 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

Nifedipine and flunarizine block amphetamine-induced behavioral stimulation in mice

5 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

Diltiazem or verapamil prevents haloperidol-induced apomorphine supersensitivity in mice

5 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

Flunarizine potentiates cocaine-induced dopamine release and motor stimulation in rats.

5 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brain

5 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

Flunarizine potentiates cocaine-induced dopamine release and motor stimulation in rats.

5 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

[3H] (-)sulpiride binding in rat striatum, cortex and anterior pituitary: an improved assay.

5 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

[3H] (-)sulpiride binding in rat striatum, cortex and anterior pituitary: an improved assay.

5 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90526-V

5 December 2022

Identifiers

1 reference

14 February 2018

1 reference

14 February 2018